TARS : Insider Transactions for Tarsus Pharmaceuticals, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Tarsus Pharmaceuticals, Inc. (TARS)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

33,110,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$ - $

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Tarsus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. Co.'s primary product candidate, TP-03, is an investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. Co. is developing product candidates to address targeted diseases with unmet medical needs, which include TP-03 for the potential treatment of Meibomian Gland Disease, TP-04 for the potential treatment of rosacea, and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	1,000	10,506	128,906
Total Buy Value	$0	$18,960	$178,661	$1,825,267
Total People Bought	0	1	2	3
Total Buy Transactions	0	1	2	4
Total Shares Sold	28,810	103,773	512,215	1,883,473
Total Sell Value	$881,586	$2,318,498	$5,911,911	$16,006,798
Total People Sold	5	6	7	10
Total Sell Transactions	5	11	29	119
End Date	2024-01-28	2023-10-27	2023-04-28	2022-04-28

Adjust Filter Settings

Records found: 211

Page 1 of 9

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Neervannan Seshadri

Chief Operating Officer

• – –

2024-03-18

4

S

$30.60

$149,297

D/D

(4,879)

64,767

-

General Counsel

• – –

2024-03-18

4

S

$30.60

$135,742

D/D

(4,436)

40,951

-

Azamian Bobak R.

President/CEO and Board Chair

• • –

2024-03-18

4

S

$30.60

$318,699

D/D

(10,415)

26,456

-

Whitfield Dianne C.

Chief Human Resources Officer

• – –

2024-03-18

4

S

$30.60

$132,008

D/D

(4,314)

34,181

-

Chief Commercial Officer

• – –

2024-03-18

4

S

$30.60

$145,840

D/D

(4,766)

54,075

-

Neervannan Seshadri

Chief Operating Officer

• – –

2024-03-15

4

OE

$0.00

$0

D/D

13,245

69,646

-

General Counsel

• – –

2024-03-15

4

OE

$0.00

$0

D/D

12,038

45,387

-

Azamian Bobak R.

President/CEO and Board Chair

• • –

2024-03-15

4

OE

$0.00

$0

D/D

28,274

36,871

-

Whitfield Dianne C.

Chief Human Resources Officer

• – –

2024-03-15

4

OE

$0.00

$0

D/D

11,711

38,495

-

Chief Commercial Officer

• – –

2024-03-15

4

OE

$0.00

$0

D/D

12,938

58,841

-

Azamian Bobak R.

President/CEO and Board Chair

• • –

2023-12-27

4

AS

$20.22

$161,760

I/I

(8,000)

830,106

-

Trevejo Jose M.

CHIEF MEDICAL OFFICER

• – –

2023-12-20

4

AS

$20.00

$45,040

D/D

(2,252)

2,251

-

Azamian Bobak R.

President/CEO and Board Chair

• • –

2023-12-20

4

AS

$19.96

$810,623

I/I

(40,000)

838,106

-

Goldberg Andrew D.

Director

– • –

2023-12-15

4

B

$18.96

$18,960

D/D

1,000

3,000

2.39

-

Director

– • –

2023-12-02

4

OE

$0.00

$0

D/D

5,000

7,000

-

Whitfield Dianne C.

Chief Human Resources Officer

• – –

2023-11-30

4

S

$16.31

$136,270

D/D

(8,355)

26,784

-

General Counsel

• – –

2023-11-30

4

S

$16.31

$136,286

D/D

(8,356)

31,966

-

Whitfield Dianne C.

Chief Human Resources Officer

• – –

2023-11-29

4

OE

$0.00

$0

D/D

23,920

35,139

-

General Counsel

• – –

2023-11-29

4

OE

$0.00

$0

D/D

23,920

40,322

-

Azamian Bobak R.

President/CEO and Board Chair

• • –

2023-11-15

4

AS

$18.01

$146,933

I/I

(8,000)

878,106

-

Azamian Bobak R.

President/CEO and Board Chair

• • –

2023-10-18

4

AS

$13.24

$105,920

I/I

(8,000)

886,106

-

Trevejo Jose M.

CHIEF MEDICAL OFFICER

• – –

2023-10-05

4

AS

$18.00

$28,872

D/D

(1,604)

4,503

-

Azamian Bobak R.

President/CEO and Board Chair

• • –

2023-09-20

4

AS

$17.21

$137,680

I/I

(8,000)

894,106

-

Morrison Scott W

Director

– • –

2023-09-15

4

OE

$0.00

$0

D/D

1,333

1,333

-

Azamian Bobak R.

President/CEO and Board Chair

• • –

2023-08-23

4

AS

$17.23

$137,840

I/I

(8,000)

902,106

-

211 Records found	1 2 3 4 5 6 7 8 9	Page 1 of 9

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.